Pear Therapeutics

Pear Therapeutics is engaged in the discovery, development, and delivery of clinically validated, software-based therapies to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a range of products and candidates in therapeutic areas including psychiatric and neurological disorders. reSET, a software product developed by Pear Therapeutics, Inc. based on behavioral therapy for substance use disorder (SUD), is the first prescription digital therapeutic (PDT) authorized by the FDA to improve outcomes for psychiatric conditions.